Cargando…
Can hyperbaric oxygen safely serve as an anti-inflammatory treatment for COVID-19?
INTRODUCTION: SARS-CoV-2 affects part of the innate immune response and activates an inflammatory cascade stimulating the release of cytokines and chemokines, particularly within the lung. Indeed, the inflammatory response during COVID-19 is likely the cause for the development of acute respiratory...
Autores principales: | Kjellberg, Anders, De Maio, Antonio, Lindholm, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456590/ https://www.ncbi.nlm.nih.gov/pubmed/33254531 http://dx.doi.org/10.1016/j.mehy.2020.110224 |
Ejemplares similares
-
Hyperbaric oxygen therapy for long COVID (HOT-LoCO), an interim safety report from a randomised controlled trial
por: Kjellberg, Anders, et al.
Publicado: (2023) -
Anti-inflammatory effects of hyperbaric oxygen on irradiated laryngeal tissues()
por: Arıcıgil, Mitat, et al.
Publicado: (2017) -
COVID-19-Induced Acute Respiratory Distress Syndrome Treated with Hyperbaric Oxygen: Interim Safety Report from a Randomized Clinical Trial (COVID-19-HBO)
por: Kjellberg, Anders, et al.
Publicado: (2023) -
Randomised, controlled, open label, multicentre clinical trial to explore safety and efficacy of hyperbaric oxygen for preventing ICU admission, morbidity and mortality in adult patients with COVID-19
por: Kjellberg, Anders, et al.
Publicado: (2021) -
Hyperbaric oxygen for treatment of long COVID-19 syndrome (HOT-LoCO): protocol for a randomised, placebo-controlled, double-blind, phase II clinical trial
por: Kjellberg, Anders, et al.
Publicado: (2022)